Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
NCT ID:
NCT01751451
Group ID:
EG001
Title:
Abiraterone Acetate and Degarelix
Description:
Group 2
Abiraterone acetate 1000 mg daily x 8 months
* Prednisone 5 mg once daily x 8 months
* Degarelix subcutaneous depot injection q 1 month x 8 months
Abiraterone acetate plus degarelix: Patients randomized to abiraterone acetate plus degarelix and prednisone (Group 2) will be instructed to take 1000 mg (four 250 mg tablets) of abiraterone acetate orally (PO) at least 1 hour before a meal and 2 hours after a meal every day and prednisone 5 mg once daily with food. Patients will also be given two subcutaneous injections of degarelix 120 mg on Cycle 1, Day 1(starting dose) and 80 mg subcutaneous doses (maintenance doses) every 28 days (±3 days) thereafter.
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
40
Other Number Affected:
5
Other Number At Risk:
40
Study:
NCT01751451
Results Section:
NCT01751451
Adverse Events Module:
NCT01751451